HomeStock ScreenerHB StockholdingsIntrinsic Value

HB Stockholdings Intrinsic Value

HB Stockholdings (HBSL) median intrinsic value is ₹90.00 from 3 valuation models (range ₹19–₹160), vs current price ₹64.19 — +40.2% upside (Trading Below Calculated Value), margin of safety 28.7%. For current market price and key ratios, visit HB Stockholdings share price screener.

Current Stock Price
₹64.19
Primary Intrinsic Value
₹90.00
Market Cap
₹51.4 Cr
+40.2% Upside
Median Value
₹90.00
Value Range
₹19 - ₹160
Assessment
Trading Below Calculated Value
Safety Margin
28.7%

HBSL Valuation Methods Summary — DCF, Graham Number & P/E

HB Stockholdings intrinsic value across 3 models vs current price ₹64.19 — upside/downside and value range per method. Browse HBSL balance sheet details for revenue, profit, balance sheet and cash flow data.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹90.00 ₹81.00 - ₹99.00 +40.2% Book Value/Share: ₹112.50, P/B: 0.8x
Revenue Multiple Method revenue ₹19.26 ₹17.33 - ₹21.19 -70.0% Revenue/Share: ₹5.00, P/S: 1.0x
Simple DCF (5Y) dcf ₹160.47 ₹128.38 - ₹192.56 +150.0% CF Growth: 15.0%, Discount: 15%
Method Types: Earnings Asset DCF Growth Dividend Conservative

HBSL Intrinsic Value vs Market Price — All Valuation Models

HB Stockholdings fair value range ₹19–₹160 vs current market price ₹64.19 across 3 valuation models. Also explore HBSL price trends to track price trends across different timeframes.

HBSL Intrinsic Value Analysis — Undervalued or Overvalued?

HB Stockholdings median intrinsic value ₹90.00, current price ₹64.19 — Trading Below Calculated Value by 40.2%, margin of safety 28.7%.

What is the intrinsic value of HBSL?

Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of HB Stockholdings (HBSL) is ₹90.00 (median value). With the current market price of ₹64.19, this represents a +40.2% variance from our estimated fair value.

The valuation range spans from ₹19.26 to ₹160.47, indicating ₹19.26 - ₹160.47.

Is HBSL undervalued or overvalued?

Based on our multi-method analysis, HB Stockholdings (HBSL) appears to be trading below calculated value by approximately 40.2%.

HBSL Financial Health — Key Ratios vs Industry Benchmarks

HB Stockholdings financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 16.00 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Return on Equity -22.2% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin -1193.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 0.04x Industry Standard: 1.0x+ Below 0.5x Measures asset utilization efficiency

HBSL Cash Flow Quality — Operating & Free Cash Flow

HB Stockholdings operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹-5 Cr ₹-6 Cr Negative Cash Flow 3/10
March 2024 ₹33 Cr ₹18 Cr Positive Free Cash Flow 8/10
March 2023 ₹-3 Cr ₹-4 Cr Negative Cash Flow 3/10
March 2022 ₹-12 Cr ₹-12 Cr Negative Cash Flow 3/10
March 2021 ₹5 Cr ₹3 Cr Positive Free Cash Flow 8/10